Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

S0820, Adenoma and Second Primary Prevention Trial (PACES)

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2016 by Southwest Oncology Group
Sponsor:
Collaborators:
National Cancer Institute (NCI)
Cancer Prevention Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Southwest Oncology Group
ClinicalTrials.gov Identifier:
NCT01349881
First received: May 5, 2011
Last updated: April 8, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2029
  Estimated Primary Completion Date: June 2024 (Final data collection date for primary outcome measure)